NAMENDA XR
Drug
Allergan Inc.
Total Payments
$35,765
Transactions
688
Doctors
480
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $2.32 | 1 | 1 |
| 2017 | $35,762 | 687 | 479 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $35,035 | 433 | 98.0% |
| Education | $730.10 | 255 | 2.0% |
Top Doctors Receiving Payments for NAMENDA XR
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Gary Small | Psychiatry | Los Angeles, CA | $351.13 | 3 |
| , MD | Internal Medicine | Tampa, FL | $278.84 | 2 |
| , M.D | Neurology | Pittsburgh, PA | $174.43 | 2 |
| , M.D | Specialist | Houston, TX | $143.45 | 1 |
| , MD | Internal Medicine | Houston, TX | $143.45 | 1 |
| , MDPA | Psychiatry | Katy, TX | $143.45 | 1 |
| David Love | — | Houston, TX | $143.45 | 1 |
| , MD | Family Medicine | Tomball, TX | $143.45 | 1 |
| , M.D | Neurology | Houston, TX | $143.45 | 1 |
| , M.D | Neurology | Webster, TX | $143.45 | 1 |
| , MD | Neurology | Houston, TX | $143.45 | 1 |
| , MD | Internal Medicine | Houston, TX | $143.45 | 1 |
| , M.D | Family Medicine | Houston, TX | $143.45 | 1 |
| Harris Hauser | — | Bellaire, TX | $143.45 | 1 |
| , MD | Psychiatry | Houston, TX | $143.45 | 1 |
| , M.D | Student in an Organized Health Care Education/Training Program | Houston, TX | $143.45 | 1 |
| , MD | Psychiatry | Sugar Land, TX | $143.45 | 1 |
| , M.D | Internal Medicine | Tomball, TX | $143.45 | 1 |
| , M.D | Psychiatry | Houston, TX | $143.45 | 1 |
| , M.D | Internal Medicine | Webster, TX | $143.45 | 1 |
| , M.D | Internal Medicine | Houston, TX | $143.45 | 1 |
| Howard Dillard | — | Webster, TX | $143.45 | 1 |
| , M.D | Neurology | Houston, TX | $143.45 | 1 |
| , M.D | Neurology | Houston, TX | $143.45 | 1 |
| , M.D | Family Medicine | Kingwood, TX | $143.45 | 1 |
Ad
Manufacturing Companies
- Allergan Inc. $35,765
Product Information
- Type Drug
- Total Payments $35,765
- Total Doctors 480
- Transactions 688
About NAMENDA XR
NAMENDA XR is a drug associated with $35,765 in payments to 480 healthcare providers, recorded across 688 transactions in the CMS Open Payments database. The primary manufacturer is Allergan Inc..
Payment data is available from 2017 to 2018. In 2018, $2.32 was paid across 1 transactions to 1 doctors.
The most common payment nature for NAMENDA XR is "Food and Beverage" ($35,035, 98.0% of total).